Search Results 551-560 of 21253 for anti-TNF drugs

1. Cyclophosphamide (Oral Route, Intravenous Route) Description and Brand Names - Mayo Clinic

   It belongs to the group of cancer medicines called alkylating agents.

2. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Additionally, if subjects are taking drugs such Vit E, Ursodeoxycholic acid, Gemfibrozil, anti TNF therapies and probiotics will be allowed if on stable ...

3. Alprazolam (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. Methylprednisolone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Anticholinergics And Antispasmodics (Oral Route, Parenteral Route, Rectal Route, Transdermal Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

6. Meloxicam (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Randomized Study of Topical Alicaforsen Enema in Antibiotic Refractory Pouchitis - Mayo Clinic

   ... therapy. Rectal products; Biological agents: Anti-tumour necrosis factor (anti - TNF) therapy and / or vedolizumab; are not permitted within 8 weeks of the ...

8. Nuclear Medicine Therapy - Overview - Mayo Clinic

   Nuclear medicine therapy is a cancer treatment that uses radioactive drugs that bind to cancer cells and destroy them. This therapy is an option for some ...

9. Acetaminophen (Intravenous Route) Before Using - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

10. Lenvatinib (Oral Route) Description and Brand Names - Mayo Clinic

    Lenvatinib is also used in combination with pembrolizumab injection as first-line treatment of advanced renal cell carcinoma (RCC), a kind of kidney cancer, ...